NASHVILLE, Tenn.--(BUSINESS WIRE)--May 16, 2005--Sarah Cannon Research Institute (SCRI) has signed a letter of intent to enter an agreement with Florida Cancer Specialists, Florida's largest privately-owned oncology/hematology practice. The relationship makes it possible for both organizations to increase the number and types of clinical trials offered, giving more patients access to the newest treatments.
"This agreement is an exciting step to expand and standardize operations with our comprehensive network of clinical researchers across the country," said Mark Cianciolo, CEO of Sarah Cannon Research Institute. "Florida Cancer Specialists has a stellar record of patient care and clinical trial development specializing in oncology and hematology. They are an ideal practice for us to partner with as we move forward with our plans for growth."